Meeting Report: N-Nitrosamine Impurity Control Strategies in the Pharmaceutical and Biotechnology Industries.
Saved in:
| Title: | Meeting Report: N-Nitrosamine Impurity Control Strategies in the Pharmaceutical and Biotechnology Industries. |
|---|---|
| Authors: | Roberts SW; Novo Nordisk A/S, Vandtårnsvej 114, DK-2860, Søborg, Denmark. osrb@novonordisk.com., Lennard A; Amgen Ltd., Uxbridge, UK., Mohan G; Merck & Co., Inc., Kenilworth, New Jersey, USA., Bernstein J; Live Oak Pharmaceutical Consulting, Inc., Raleigh, North Carolina, USA., Cauchon NS; Amgen Inc., Thousand Oaks, California, USA., Cole S; Live Oak Pharmaceutical Consulting, Inc., Raleigh, North Carolina, USA., Curristin N; Live Oak Pharmaceutical Consulting, Inc., Raleigh, North Carolina, USA., Huynh-Ba K; Pharmalytik, LLC, Newark, Delaware, USA., Kolz CN; Pfizer Inc., Groton, Connecticut, USA., Murti C; Merck & Co., Inc., Kenilworth, New Jersey, USA., Tang K; Genentech, Inc., South San Francisco, California, USA. |
| Source: | The AAPS journal [AAPS J] 2021 Jul 13; Vol. 23 (4), pp. 94. Date of Electronic Publication: 2021 Jul 13. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Association of Pharmaceutical Scientists Country of Publication: United States NLM ID: 101223209 Publication Model: Electronic Cited Medium: Internet ISSN: 1550-7416 (Electronic) Linking ISSN: 15507416 NLM ISO Abbreviation: AAPS J Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1550-7416 |
|---|---|
| DOI: | 10.1208/s12248-021-00618-5 |
